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LETTERS TO THE EDITORS 
Epidemic vancomycin-resistant Enterococcus 
faecium in the UK 
To the Editors: 
Vancomycin-resistant enterococci (VRE) are isolated 
with increasing frequency in hospitals and pose a major 
threat especially to immunocompromised patients and 
others in specialist units. From the time they were first 
reported [1,2], the Laboratory of Hospital Infection has 
received VRE from hospitals throughout the UK in 
order to further elucidate the epidemiology of these 
organisms. Although there have been reports of VRE 
in particular hospitals in the UK [2-121, no data have 
been presented on the national distribution of these 
organisms. 
Between 1987 and 1994, approximately 500 
isolates of VRE (Enterococcus faecium, 86%; Enterococcus 
faecalis, 11%; and Enterococcus avium, 3%) were referred 
from 44 hospitals. This series includes only enterococci 
with acquired vancomycin resistance and excludes 
the intrinsically vancomycin-resistant species such 
as Enterococcus gallinarum, Enterococcus casselipavus and 
Enterococcus jlavescens. The hospitals involved ranged 
fiom large teaching hospitals to district general 
hospitals. At one district general hospital, vancomycin 
had not been in use for 6 months prior to VRE 
isolation [7]. Both phenotypes of VRE - VanA 
(resistant to vancomycin and teicoplanin) and VanB 
(resistant to vancomycin, but sensitive to teicoplanin in 
vitro) - were received, although isolates with the VanA 
phenotype were predominant (80%). 
Although most institutions referred only one 
isolate, clusters of VRE were received from 14 
hospitals. The foci of these clusters were specialist units 
such as renal, hematological, intensive care and liver 
units, but strains had also spread to other departments. 
In several hospitals, VRE have become endemic with 
the same strain isolated over a number of years. On 
investigation of these clusters, using molecular tech- 
niques, we found that, although each hospital may have 
one or two strains which predominate, a number of 
other strains are often involved, some of which have 
been found to carry the vancomycin resistance genes 
on plasmids of similar molecular weight [13]. This 
suggests that the epidemiology of nosocomial VRE 
involves both the spread of strains between patients and 
the spread of the vancomycin resistance genes between 
strains. 
Typing of vancomycin-resistant E.  faecium (VREM) 
also suggests that, nationwide, a large number of 
heterogeneous strains are involved. Nevertheless, eight 
strains have been isolated at more than one hospital as 
a result of what appear to be instances of interhospital 
spread. Five of these fulfil our definition of an epidemic 
strain (isolation from at least two patients in each of two 
or more hospitals) and have been designated epidemic 
VREM (EVREM) strains 1 to 5. In the majority of 
cases, spread occurred among two or three hospitals in 
the same city. However, one of these strains, EVREM- 
3, was isolated at seven hospitals in the London 
area during 1993 and 1994, and was responsible for 
prolonged outbreaks in the renal units of two of them. 
In the first 9 months of 1995, this strain was isolated at 
a further four hospitals in the London area. The 
majority of isolates of EVREM-3 are multiresistant, 
with high-level resistance to vancomycin, teicoplanin, 
gentamicin, streptomycin and penicillin. At present, we 
are unable to draw any firm conclusions as to the mode 
of interhospital spread. However, in one instance, 
the index patient in a bone marrow transplant unit 
(BMTU) had been transferred fiom the BMTU of 
another hospital where the same strain of VREM had 
been fiequently isolated. 
Similar cases of interhospital spread have recently 
been reported in the USA [14,15]. These and our own 
observations highlight the urgent need for hospitals to 
implement infection-control policies to prevent the 
spread of VRE both within and between hospitals. 
Recommendations have been established in the USA 
[ 161. We suggest that hospitals in the UK and elsewhere 
should refer isolates of VRE to reference laboratories 
to monitor the spread of VREM and to ensure that 
infection-control teams are kept informed of their 
epidemic potential, as is done in the case of epidemic 
strains of methicillin-resistant Staphylococcus aureus. 
Donald Morrison, Neil Woodford 
and Barry D. Cookson 
London, United Kingdom 
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listeriosis associated with pregnancy and human 
immunodeficiency virus (HIV) infection 
To the Editors: 
Although Listeria monocytogenes has not been considered 
a pathogen associated with human immunodeficiency 
virus (HIV) infection [l], a number of recent case 
reports have described listeriosis in such patients [2-51. 
In our 1000-bed hospital (for a population of approxi- 
mately 450,000), only four cases of listeriosis were 
reported in 1991. Three of the patients were women, 
two of whom were HIV-positive. 
Patient one: A 40-year-old woman with an 11 -year 
history of intravenous drug abuse, who had been 
diagnosed as HIV-positive 4 years previously, was 
admitted to hospital with a 3-week history of confixion 
and altered consciousness, and 3 days of headache and 
vomiting. At the time of admission, she was cachectic 
with a body temperature of 39°C and stiffness in 
the neck. Cerebral spinal fluid (CSF) examination 
revealed 850 leukocytes/mm3 (95% lymphocytes), and 
concentrations ofglucose at 10 mg/100 mL and protein 
at 1.5 g/L. Initially, meningitis caused by Mycobacterium 
tuberculosis was suspected and appropriate antibiotic 
therapy was started. This medication was changed to 
ampicillin and gentamicin when L. monocytogenes was 
isolated in blood cultures, but not from CSE After 25 
days, the patient was afebrile and had recovered normal 
cortical function, and was therefore discharged from 
hospital. 
Patient two: A 25-year-old woman, who was 25 
weeks into pregnancy, was herself not a drug abuser, 
but associated with addicts. She was admitted to 
hospital with a 7-day history of fever, chills, lower 
back pain and difficulty in swallowing. Findings a t  
the time of admission included a body temperature of 
38.9"C, malar erythema, a reddened pharynx with 
oral thrush, a right epistaxis, soft hepatomegaly and 
pain on kidney percussion. Obstetric examination 
findings were normal. Examination of peripheral 
blood revealed 2200 leukocytes/mm' (53% seg- 
mented, 13% lymphocytes and 33% band forms) and 
29,000 platelets/mm'. O n  isolation of L. monocyto- 
genes from blood cultures, treatment with ampicillin 
and tobramycin were started. Five days after 
admission, .uterine contractions began and a dead fetus 
was spontaneously expelled. Bone marrow puncture 
revealed megakaryocytic thrombocytopenic purpura, 
and HIV infection was later diagnosed by enzynie- 
liaked immunosorbent assay (ELISA) and Western 
blot testing. After 13 days, the patient had improved 
both clinically and symptomatically, and was therefore 
discharged from hospital. 
Patient three: A 33-year-old woman, who was 29 
weeks into pregnancy, was admitted to hospital in 
preterm labor with a fever of 37.7"C. After admission, 
uterine contractions began and a dead fetus was 
delivered. Samples from the fetal anus, pharynx, nose, 
placenta and lochia were sent to the microbiology 
laboratory. Treatment with ampicillin and gentamicin 
was started when L. monocytogenes was isolated from all 
samples. Peripheral blood examination revealed 18,000 
leukocytes/mm' (80% segmented, 12% lymphocytes). 
Serology for Treponema pallidum, the TORCH (toxo- 
plasma, others, rubella, cytomegalovirus and herpes) 
series of microorganisms and HIV was negative. After 
